| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 |
| Total Revenue | 62 | 103 | 216 | 789 |
| Cost of Revenue | 35 | 64 | 145 | 336 |
|
| Gross Profit | 27 | 39 | 71 | 453 |
|
| Operating Expenses |
| Research Development | 79 | 85 | 83 |
-
|
| Selling General and Administrative | 220 | 212 | 208 | 268 |
| Non Recurring | 0 | (0) | 36 | 147 |
| Others |
-
|
-
|
-
| 80 |
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (273) | (258) | (256) | (42) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | (1) | (16) | (23) | 46 |
| Earnings Before Interest And Taxes | (274) | (275) | (279) | 4 |
| Interest Expense | 29 | 13 | 43 | 21 |
| Income Before Tax | (302) | (287) | (322) | (18) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest | 1 |
-
|
-
| 2 |
| |
| Net Income From Continuing Ops | (302) | (287) | (322) | (16) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | (302) | (287) | (322) | (16) |
| Preferred Stock And Other Adjustments | (1) |
-
| 1 |
-
|
|
| Net Income Applicable To Common Shares | ($302) | ($287) | ($321) | ($16) |
0.31% Nasdaq 
0.05%
Income Statement
